Burleson & Company »

Acer Therapeutics shares owned by Burleson & Company

Quarter-by-quarter ownership of Acer Therapeutics shares owned by Burleson & Company from 13F filings

Historical chart of Burleson & Company investment in Acer Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acer Therapeutics held by Burleson & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acer Therapeutics by Burleson & Company

Quarter filed Position value Share count Share price at filing
2022-12-31 $916 365 2.51
2022-09-30 $999 365 2.74
2022-06-30 $0 365 0.00
2022-03-31 $999 365 2.74
2021-12-31 $999 365 2.74
2021-09-30 $999 365 2.74
2021-06-30 $999 365 2.74
2021-03-31 $999 365 2.74

Top funds holding Acer Therapeutics